UBS/CALL/ALCON AG/80.001/0.1/20.09.24 Share Price

Warrant

KALC2U

CH1246586916

Real-time Bid/Ask 09:03:14 05/07/2024 BST
0.34 CHF / 0.36 CHF -5.41% Intraday chart for UBS/CALL/ALCON AG/80.001/0.1/20.09.24
3 months+27.59%
6 months+311.11%
Date Price Change
04/07/24 0.37 +23.33%
03/07/24 0.3 -11.76%
02/07/24 0.34 -2.86%
25/06/24 0.35 -5.41%

Delayed Quote Swiss Exchange

Last update July 04, 2024 at 04:20 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ALCON INC.
Issuer UBS
KALC2U
ISINCH1246586916
Date issued 20/03/2023
Strike 80 CHF
Maturity 20/09/2024 (78 Days)
Parity 10 : 1
Emission price 0.25 CHF
Emission volume N/A
Settlement Physisch
Currency CHF

Technical Indicators

Highest since issue 0.6 CHF
Lowest since issue 0.09 CHF
Spread 0.01 CHF
Spread %2.70%

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
89.81 USD
Average target price
93.95 USD
Spread / Average Target
+4.61%
Consensus
  1. Stock Market
  2. Warrants
  3. KALC2U Warrant